Skip to main content

. 1993 Jan;56(1):114–115. doi: 10.1136/jnnp.56.1.114

Buspirone in progressive myoclonus epilepsy.

M R Pranzatelli, D Franz, E Tate, J M Martens

PMCID: PMC1014783 PMID: 7679141

114

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Koskiniemi M., Hyyppä M., Sainio K., Salmi T., Sarna S., Uotila L. Transient effect of L-tryptophan in progressive myoclonus epilepsy without Lafora bodies: clinical and electrophysiological study. Epilepsia. 1980 Aug;21(4):351–357. doi: 10.1111/j.1528-1157.1980.tb04082.x. [DOI] [PubMed] [Google Scholar]
Löscher W., Czuczwar S. J. Evaluation of the 5-hydroxytryptamine receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin in different rodent models of epilepsy. Neurosci Lett. 1985 Sep 30;60(2):201–206. doi: 10.1016/0304-3940(85)90244-7. [DOI] [PubMed] [Google Scholar]
Marsden C. D., Schachter M. Assessment of extrapyramidal disorders. Br J Clin Pharmacol. 1981 Feb;11(2):129–151. doi: 10.1111/j.1365-2125.1981.tb01118.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
Trouillas P., Brudon F., Adeleine P. Improvement of cerebellar ataxia with levorotatory form of 5-hydroxytryptophan. A double-blind study with quantified data processing. Arch Neurol. 1988 Nov;45(11):1217–1222. doi: 10.1001/archneur.1988.00520350055016. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES